| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Thursday’s Close |
|---|---|---|---|---|---|
| NVS | Novartis AG | $85.13 | $197.65B | N/A |
Roche's NDA for SMA Drug Gets Expanded Review From FDA
http://www.zacks.com/stock/news/861186/roches-nda-for-sma-drug-gets-expanded-review-from-fda?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-861186
Apr 08, 2020 - The FDA stretches the review timeline of Roche's (RHHBY) NDA for risdiplam by three months, which is being evaluated to treat spinal muscular atrophy. A decision is now pending on Aug 24, 2020.
0
Biotech Stocks, ETFs to Gain on COVID-19 Vaccine & Drug Progress
http://www.zacks.com/stock/news/859545/biotech-stocks-etfs-to-gain-on-covid-19-vaccine-drug-progress?cid=CS-ZC-FT-etf_news_and_commentary-859545
Apr 07, 2020 - The race to introduce a vaccine and drug for COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.
0
The Zacks Analyst Blog Highlights: Johnson & Johnson, Merck & Co, Novartis, PayPal and IBM
http://www.zacks.com/stock/news/858931/the-zacks-analyst-blog-highlights-johnson-johnson-merck-co-novartis-paypal-and-ibm?cid=CS-ZC-FT-press_releases-858931
Apr 07, 2020 - The Zacks Analyst Blog Highlights: Johnson & Johnson, Merck & Co, Novartis, PayPal and IBM
0
Top Stock Reports for J&J, Merck, Novartis & Others
http://www.zacks.com/research-daily/857167/top-stock-reports-for-jj-merck-novartis-others?cid=CS-ZC-FT-research_daily-857167
Apr 06, 2020 - Top Stock Reports for J&J, Merck, Novartis & Others
0
NVS vs. NVO: Which Stock Should Value Investors Buy Now?
http://www.zacks.com/stock/news/849177/nvs-vs-nvo-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-849177
Apr 01, 2020 - NVS vs. NVO: Which Stock Is the Better Value Option?
0
Lilly's Taltz Gets FDA Nod for Plaque Psoriasis in Children
http://www.zacks.com/stock/news/847430/lillys-taltz-gets-fda-nod-for-plaque-psoriasis-in-children?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-847430
Mar 31, 2020 - The FDA approves Eli Lilly's (LLY) sBLA for Taltz injection to treat pediatric patients with moderate to severe plaque psoriasis. Stock up.
0
Novartis Reports Data on Inclisiran, CHMP Positive on Zolgensma
http://www.zacks.com/stock/news/845181/novartis-reports-data-on-inclisiran-chmp-positive-on-zolgensma?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-845181
Mar 30, 2020 - Novartis (NVS) announces pipeline updates on inclisiran and regulatory updates on Cosentyx and Zolgensma.
0
4 Reasons Drug Stocks Are a Buy Right Now
https://www.fool.com/investing/2020/03/30/4-reasons-drug-stocks-are-a-buy-right-now.aspx?source=iedfolrf0000001
Mar 30, 2020 - Drug developers took center stage as the world looks to these companies to deliver an answer to COVID-19.
0
Charges dropped for topless protesters at Sanders NV rally
https://www.startribune.com/charges-dropped-for-topless-protesters-at-sanders-nv-rally/569178702/
Mar 27, 2020 - Criminal charges have been dropped in Nevada against three topless protesters who were arrested at a rally for Democratic presidential hopeful Bernie Sanders in Carson City in February.
0
3 Things to Know if Chloroquine Wins the COVID-19 Treatment Race
https://www.fool.com/investing/2020/03/27/3-things-to-know-if-chloroquine-wins-the-covid-19.aspx?source=iedfolrf0000001
Mar 27, 2020 - An old malaria drug may unseat newer investigational coronavirus treatments -- if data is confirmed.
0
Pages: 1
Page 1